• -
  • English
  • Japanese
  • Korean
表紙
市場調查報告書
商品編碼
1025198

栓塞保護設備的全球市場預測(2021年∼2027年)

Embolic Protection Devices Market 2021-2027
出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球栓塞保護設備(EPD)的市場規模在預測期間內預計將以8.0％的年複合成長率急速擴大。栓塞保護裝置用於SVG（大隱靜脈移植）、頸動脈疾病、AS、PAD、急性心肌梗塞等多種適應症。流行病學研究表明，在冠狀動脈旁路移植術 (CABG) 後的前 6 個月內，高達 12% 的 SVGs 發生閉塞，約 3.4% 在 2-3 週內發生閉塞。

本報告提供全球栓塞保護設備市場相關調查分析，提供市場概要，市場決策要素，市場區隔，競爭情形，各地區分析，主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和最新市場趨勢
  • 法律規章

第3章 競爭情形

  • 競爭的儀表板
  • 主要策略分析
  • 主要企業分析
    • Abbott
    • Boston Scientific Corp.
    • Cardinal Health, Inc.
    • Medtronic plc

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各產品的全球栓塞保護設備產業市場
    • 過濾器設備
    • 阻塞設備
  • 各應用領域的全球栓塞保護設備市場
    • 心血管及末梢
    • 神經血管
  • 各銷售管道的全球栓塞保護設備市場
    • 門診病人手術中心
    • 獨立型CATH實驗室
    • 醫院
    • 專門心臟中心

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Abbott
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • Cardioptimus, LLC**
  • Cardiovascular Systems, Inc.
  • Contego Medical, LLC
  • Filterlex**
  • Innovative Cardiovascular Solutions, LLC**
  • InspireMD Inc.
  • Medtronic plc
  • NIPRO
  • Protembis GmbH**
  • Silk Road Medical
  • Terumo Corp.
  • Transverse Medical, Inc.**
  • VENUS MEDTECH
目錄
Product Code: OMR2023506

Global Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)

The embolic protection devices market is anticipated to grow at a rapid CAGR of 8.0% during the forecast period. Embolic protection devices are used for various indications such as SVG, carotid artery disease and others, including AS, PAD, and acute myocardial infarction. Epidemiological studies stated, up to 12% of SVGs become occluded within the first six months after coronary artery bypass graft (CABG), with approximately 3.4% occluding as early as second to third weeks. 

Multiple clinical studies published, the use of EPDs has reduced the 30-day major adverse cardiovascular events (MACE) rate by 40-50%. As embolization during endovascular interventional procedures has become increasingly prevalent, and most likely, all endovascular interventions generate embolic material. Careful use of EPDs to avoid atheroembolization during arterial interventions improves the clinical outcome in carotid, coronary and lower extremity artery interventions. Therefore, gaining significant popularity with the rising burden of various cardiac diseases globally.

The embolic protection devices market is segmented based on product, application, and end-user. Based on product, the market is segmented into filter devices and occlusion devices. Based on application, the market is categorized into cardiovascular & peripheral and neurovascular. Based on end-user, the market is fragmented into ambulatory surgery centers, freestanding CATH labs, hospitals, and specialty cardiac centers. In 2019, the cardiovascular & peripheral application segment accounted for the largest share of more than 60.0% of the global embolic protection devices market. PCI (Percutaneous Coronary Intervention) with stent placement is the most widely used revascularization procedure for SVG (Saphenous Vein Graft) lesions. Both cardiovascular & peripheral interventions with the percutaneous technique are associated with critical risk of distal embolization, which limits the clinical benefit to the patient. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiovascular & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. Therefore, market players are offering innovative EPDs suitable for cardiovascular & peripheral interventions.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe is one of the significant markets for embolic protection devices, accounting for a large share in 2019. The rising awareness of embolic protection devices for treating various embolic complications associated with treatment procedures of CAD, PAD and valvular heart diseases coupled with improved healthcare infrastructure, various favorable guidelines and availability of technologically advanced embolic protection devices are driving the growth of the embolic protection devices market in the region.

Lastly, vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market for several years. Such inorganic initiatives will complement vendors' organic growth strategies, thereby gaining traction among end-users in the market. The market is dominated by Boston Scientific, Abbott, and Medtronic. Boston Scientific is the market leader with its innovative product line of SENTINEL Cerebral Protection System, FilterWire EZ, Sentry, and FILTERWIRE EZ Embolic Protection System for SVGs for a wide range of indications, including SVG, carotid artery disease, and others.

Research Methodology

The market study of the global embolic protection devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research-papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Embolic Protection Devices Market Research and Analysis by Product

Global Embolic Protection Devices Market Research and Analysis by Application

Global Embolic Protection Devices Market Research and Analysis by End-user

The Report Covers

Comprehensive research methodology of the global embolic protection devices market.

This report also includes a detailed and extensive market overview with the key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global embolic protection devices market.

Insights about market determinants which are stimulating the global embolic protection devices market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Cardinal Health, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Medtronic plc
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.1. Opportunities

5. Market Segmentation

  • 5.1. Global Embolic Protection Devices Industry Market by Product
    • 5.1.1. Filter Devices
    • 5.1.2. Occlusion Devices
  • 5.2. Global Embolic Protection Devices Market by Application
    • 5.2.1. Cardiovascular & Peripheral
    • 5.2.2. Neurovascular
  • 5.3. Global Embolic Protection Devices Market by Sales Channel
    • 5.3.1. Ambulatory Surgery Centers
    • 5.3.2. Freestanding CATH Labs
    • 5.3.3. Hospitals
    • 5.3.4. Specialty Cardiac Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott
  • 7.2. Boston Scientific Corp.
  • 7.3. Cardinal Health, Inc.
  • 7.4. Cardioptimus, LLC**
  • 7.5. Cardiovascular Systems, Inc.
  • 7.6. Contego Medical, LLC
  • 7.7. Filterlex**
  • 7.8. Innovative Cardiovascular Solutions, LLC**
  • 7.9. InspireMD Inc.
  • 7.10. Medtronic plc
  • 7.11. NIPRO
  • 7.12. Protembis GmbH**
  • 7.13. Silk Road Medical
  • 7.14. Terumo Corp.
  • 7.15. Transverse Medical, Inc.**
  • 7.16. VENUS MEDTECH

LIST OF TABLES

  • 1. GLOBAL EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 2. GLOBAL FILTER DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL OCCLUSION DEVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 5. GLOBAL CARDIOVASCULAR & PERIPHERAL MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL NEUROVASCULAR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 8. GLOBAL AMBULATORY SURGERY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL FREESTANDING CATH LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL SPECIALTY CARDIAC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICA EMBOLIC PROTECTION DEVICESMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET RESEARCHAND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 16. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 18. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 19. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 20. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 24. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 25. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL EMBOLIC PROTECTION DEVICESMARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 2. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL EMBOLIC PROTECTION DEVICESMARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 4. GLOBAL EMBOLIC PROTECTION DEVICESMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. THE US EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. UK EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. SPAIN EMBOLIC PROTECTION DEVICESMARKET SIZE, 2020-2027 ($ MILLION)
  • 12. ROE EMBOLIC PROTECTION DEVICESMARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)